The range of medical opinions and videos, combined with and problems reading long posts at the moment (various reasons) are beginning to cause me some degree of anxiety, and adding to my confusion. So I'd like some straight, simple information, if possible.
I'm failing to understand this completely despite a lot of reading. Forgive my detailed questions, but I see no better place to seek relief my anxieties than here! I see my consultant in a month or so, and am awaiting results from my last 3 blood tests (which have been a real pain to chase up - consultant's printer not working, my GP failing to receive results that were sent…).
I'm 13q14 deletion mutated (pretty sure I've got that right) diagnosed over 4 years ago and at the edge of deciding on treatment (had none yet). I had swine 'flu and influenza A which in March-April 2016 led to bilateral pneumonia and a month in hospital. I had a history of chronic fatigue following a Parvo B19/rheumatic fever-like infection over 20 years ago. I was vitamin D deficient (now fixed for over 3 years) and low B12 (I have injections every 3 months).
After a lot of reading, this is how I sum up the current state for my mutated 13g del state:
- FCR is - as I understand - not advised as I'm aged 65 and had recent pneumonia
- Ibrutinib has side-effects but is available in the UK (I think?)
- acalabrutinib is less toxic and 2nd-generation but availability is uncertain
- other "TGR-1202 (PI3K inhibitors)" are in the pipeline (I've noted idelalisib, duvelisib and ofatumumab but have no idea what these do, how effective they may be, or what the long-term effects are because they're so new.
So I don't know how to assess the situation as I still don't fully understand what much of the more recent material means, despite trying, I can't tease out the facts relevant to my case. I also understand that response to treatment is individual, which kinda makes it even harder to work out how to make a choice.
Finally, in the UK I don't yet know what's available yet, or in which regions - I'm in the East Midlands. So I could wait and see as I'm still just managing.
Below were my last results, from a few years ago:
====
...a clone with heterozygous 13q-deletion (49%)
Karyotype: nuc ish 6 (CEP6 x 2, TNFAIP3x 2, PRDM1 x 2) , 8q24 (MYC prox x 2, MYC dist x 2), 11 (CEP11 x 2, ATM x 2, FDX x 2), 12q13 (DDIT3 prox x 2, DDIT3 dist x 2), *13q14 (D13S319 x 1, D13S25 x 1)*, 14q32 (IGH prox x 2, IGH dist x 2), 17 (P53 x 2, MPO x 2)
Vh 2-5 mutated (90.1)